Showing results (301-310 of 737) with videos related to
Sort By:
Pageof 74
Journal of the National Cancer Institute|March 1, 1995
Obesity and therapy-related toxicity in patients treated for small-cell lung cancerM S Georgiadis, S M Steinberg, L A Hankins, et al.The British Journal of Dermatology|September 1, 1980
Sister chromatid exchange and chromosome aberration rates in a group of psoriatics before and after a course of PUVA treatmentM J Faed, L Williamson, S Peterson, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 1, 1997
Smoking, gender, and survival association with allele loss for the LOH11B lung cancer region on chromosome 11G Schreiber, K M Fong, B Peterson, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 25, 2014
EGFR biomarkers predict benefit from vandetanib in combination with docetaxel in a randomized phase III study of second-line treatment of patients with advanced non-small cell lung cancerJ V Heymach, S J Lockwood, R S Herbst, et al.Genes, Chromosomes & Cancer|April 29, 1998
Mutational inactivation of aminoacylase-I in a small cell lung cancer cell lineR M Cook, W A Franklin, M D Moore, et al.Photochemistry and Photobiology|March 1, 1993
Action spectra for the trans to cis photoisomerisation of urocanic acid in vitro and in mouse skinN K Gibbs, M Norval, N J Traynor, et al.Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|January 1, 1992
Effect of triiodothyronine on the expression of T cell markers and immune function in thyroidectomized White Leghorn chickensB E Johnson, J A Marsh, D B King, et al.Chest|January 1, 1997
Obstructive atelectasis in patients with small cell lung cancer. Incidence and response to treatmentA K Vaaler, J M Forrester, M Lesar, et al.The British Journal of Dermatology|December 1, 1993
A comparison of narrow band phototherapy (TL-01) and photochemotherapy (PUVA) in the management of polymorphic light eruptionD Bilsland, S A George, N K Gibbs, et al.Chest|July 1, 1996
Retreatment of patients surviving cancer-free 2 or more years after initial treatment of small cell lung cancerJ P Chute, M J Kelley, D Venzon, et al.Pageof 74